- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Diabetes mellitus remission observed in first year following bariatric surgery, reports research

A new study published in the journal of Diabetes Research and Clinical Practice showed that following bariatric surgery, patients with long-standing type 2 diabetes mellitus experienced remission. Also, results were closely correlated with β-cell activity and the percentage of total weight lost.
The β-cell function appears to have reached a point of no return in patients with type 2 diabetes that has been present for more than 10 years. Observing the first-phase insulin secretion in long-term T2DM patients with diabetes remission and investigating the major determinants of diabetes remission in patients with a period of T2DM ≥ 10 years who went through bariatric surgery, which includes the outcomes of insulin-treated patients (I-T2DM) and non-insulin-treated patients (NI-T2DM), were the goals of this study.
The patients who had bariatric surgery and have had type 2 diabetes for at least 10 years were included retrospectively and monitored. An HbA1c < 6.5% (48 mmol/mol) at least three months after stopping hypoglycemic medications was considered remission of diabetes. The patients who were in remission from diabetes had an intravenous glucose tolerance test (IVGTT).
Nearly, 59.6% of the 203 individuals with T2DM who had been treated with insulin prior to bariatric surgery had been with the disease for at least 10 years. Remission rates at one, two, and three years after surgery were 65.6%, 53.8%, and 41.9%, respectively.
According to Cox regression analysis, the percentage of total weight loss (%TWL) and β-cell function had the strongest correlations with the probabilities of remission one year after bariatric surgery. In 50 individuals with diabetic remission, the first-phase insulin production peak was around 5–8 times the fasting insulin level.
Overall, this study found that one year following bariatric surgery, the diabetes remission rate for T2DM patients who have had the disease for at least ten years can still exceed two-thirds. But between years 1 and 3, the remission rate dropped by around 10% a year, underscoring the significance of long-term monitoring for these individuals.
Source:
Zhang, N., Zhou, B., Wang, H., Xue, X., Huang, Y., Wang, S., Wang, Z., Niu, W., Liu, B., Nie, Y., Li, Z., Zhang, L., Wang, P., Chou, S., Yao, L., Ran, S., Lv, J., Liu, G., Li, G., … ODHM(Obesity and Diabetes Health Management) Study Group. (2025). Predictors of diabetes remission after bariatric surgery in patients with type 2 diabetes mellitus duration ≥ 10 years: A retrospective cohort study. Diabetes Research and Clinical Practice, 112164, 112164. https://doi.org/10.1016/j.diabres.2025.112164
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751